Canalblog
Suivre ce blog Administration + Créer mon blog
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
5 août 2015

SHIRE ACQUIRES FORESIGHT BIOTHERAPEUTICS FOR $300MN

SHIRE ACQUIRES FORESIGHT BIOTHERAPEUTICS FOR $300MN
SHIRE ACQUIRES FORESIGHT BIOTHERAPEUTICS FOR $300MN Shire to Buy Foresight Biotherapeutics for $300 Million Shire PLC has agreed to buy a privately held eye-drug company for $300 million in a deal that would add another promising ophthalmology treatment...
Publicité
Publicité
29 mai 2015

May 27, 2015 Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2015

May 27, 2015 Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2015
May 27, 2015 Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2015 Press release distribution, EDGAR filing, XBRL, regulatory filings | Business Wire The global leader in press release distribution and regulatory disclosure. Public relations...
15 mai 2015

Eleven Biotherapeutics Presents Clinical Data on EBI-005 for the Treatment of Dry Eye Disease and Allergic Conjunctivitis

Eleven Biotherapeutics Presents Clinical Data on EBI-005 for the Treatment of Dry Eye Disease and Allergic Conjunctivitis
Eleven Biotherapeutics Presents Clinical Data on EBI-005 for the Treatment of Dry Eye Disease and Allergic Conjunctivitis at ARVO 2015 Annual Meeting NASDAQ:EBIO - Finances Eleven Biotherapeutics, Inc. http://www.finances.com Eleven Biotherapeutics, Inc....
5 mai 2015

NOVAGALI/SANTEN

NOVAGALI/SANTEN
Home | France | SantenPharmaceutical http://www.santen.eu PIPELINE: pipeline To Meet Global Medical Needs with Our Networks Covering Japan, the United States, Europe, and Asia Developing new pharmaceuticals entails a long period of over 10 years, as well...
23 avril 2015

Eyenuk's EyeArt automated high-throughput diabetic retinopathy screening receives CE Mark

Eyenuk's EyeArt automated high-throughput diabetic retinopathy screening receives CE Mark
Eyenuk's EyeArt automated high-throughput diabetic retinopathy screening receives CE Mark Eyenuk Inc. Eyenuk Inc. Website http://www.eyenuk.com Eyenuk, Inc. announced today that it received CE Marking for its pioneering EyeArt software, a suite of advanced...
Publicité
Publicité
17 avril 2015

Amakem Therapeutics

Amakem Therapeutics
AMAKEM THERAPEUTICS Amakem is a clinical stage ophthalmology company developing innovative new treatments for serious eye conditions. The Company’s lead program is based on AMA0076, a novel, locally-acting Rho kinase (ROCK) inhibitor, in clinical development...
11 avril 2015

Ocular Therapeutix

Ocular Therapeutix
Link: http://www.ocutx.com OCULAR THERAPEUTIX EYE DRUG FAILS SECOND STUDY 7 Apr 2015 | PharmaBusiness Daily Ocular Therapeutix says its lead eye drug failed to meet one of the main goals in a second late-stage study, Reuters reports. The drug, OTX-DP,...
9 avril 2015

U.S. FDA Grants Priority Review to Lifitegrast NDA for the Treatment of Dry Eye Disease in Adults

 U.S. FDA Grants Priority Review to Lifitegrast NDA for the Treatment of Dry Eye Disease in Adults
Shire has added a new press release to the Company's web site. To view the release, please click on the link below: http://www.shire.com/shireplc/en/investors/investorsnews/irshirenews?id=1089 See full text copy below: U.S. FDA Grants Priority Review...
3 avril 2015

TEARLAB DEVICE

TEARLAB DEVICE
Link: http://www.tearlab.com Product Information What is TearLab? Manage Your Dry Eye Patients with Confidence The TearLab Osmolarity System is the first objective and quantitative test for diagnosing and managing Dry Eye patients. Fast and accurate results...
2 avril 2015

Bausch + Lomb Eye Questionnaire

Bausch + Lomb Eye Questionnaire
Link: eyeexamchecklist Make the most of your visit For an effective eye examination, your eye care professional needs to know as much as possible about you. Fill out this form to remind you of your concerns — then print it out and take it with you. 1....
1 avril 2015

The TearScience solution for Meibomian Gland Dysfunction

 The TearScience solution for Meibomian Gland Dysfunction
LINK: http://tearscience.com/en/ Give MGD a Second Glance Meibomian Gland Dysfunction is treatable. The TearScience® Solution for MGD allows eye care professionals to safely and effectively identify, diagnose, and treat MGD in four easy steps. With 86%...
9 février 2015

TEARFILM

Link: www.tearfilm.org
8 février 2015

TearScience website

Link to TearScience Website: http://tearscience.com/en/
8 février 2015

TearScience® Achieves Korean HIRA Approval

TearScience® Achieves Korean HIRA Approval TearScience’s LipiFlow® Receives HIRA Patient Payment Approval, Paving the Way to Commercial Launch in Korea MORRISVILLE, N.C.,—May 19, 2014—TearScience®, Inc., a privately held medical device company, today...
Publicité
Publicité
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
Newsletter
Visiteurs
Depuis la création 33 340
Publicité